SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-17-002851
Filing Date
2017-11-07
Accepted
2017-11-07 15:42:45
Documents
39
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q proteo_10q-093017.htm 10-Q 177042
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER proteo_ex3101.htm EX-31.1 9306
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER proteo_ex3102.htm EX-31.2 8996
4 CERTIFICATION proteo_ex3200.htm EX-32 5172
  Complete submission text file 0001683168-17-002851.txt   1010268

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pteo-20170930.xml EX-101.INS 96375
6 XBRL SCHEMA FILE pteo-20170930.xsd EX-101.SCH 13394
7 XBRL CALCULATION FILE pteo-20170930_cal.xml EX-101.CAL 29369
8 XBRL DEFINITION FILE pteo-20170930_def.xml EX-101.DEF 22147
9 XBRL LABEL FILE pteo-20170930_lab.xml EX-101.LAB 93293
10 XBRL PRESENTATION FILE pteo-20170930_pre.xml EX-101.PRE 75838
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

IRS No.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30728 | Film No.: 171183241
SIC: 2834 Pharmaceutical Preparations